UNIVERSAL HEALTH SERVICES-B (UHS) Fundamental Analysis & Valuation
NYSE:UHS • US9139031002
Current stock price
184.04 USD
-1.05 (-0.57%)
At close:
184.25 USD
+0.21 (+0.11%)
After Hours:
This UHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. UHS Profitability Analysis
1.1 Basic Checks
- In the past year UHS was profitable.
- In the past year UHS had a positive cash flow from operations.
- In the past 5 years UHS has always been profitable.
- Each year in the past 5 years UHS had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 9.59%, UHS belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
- The Return On Equity of UHS (20.46%) is better than 89.00% of its industry peers.
- UHS's Return On Invested Capital of 12.52% is amongst the best of the industry. UHS outperforms 87.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 8.85%.
- The last Return On Invested Capital (12.52%) for UHS is above the 3 year average (10.23%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.59% | ||
| ROE | 20.46% | ||
| ROIC | 12.52% |
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
1.3 Margins
- With an excellent Profit Margin value of 8.57%, UHS belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
- In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
- UHS's Operating Margin of 11.48% is amongst the best of the industry. UHS outperforms 82.00% of its industry peers.
- UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.48% | ||
| PM (TTM) | 8.57% | ||
| GM | N/A |
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
2. UHS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
- UHS has less shares outstanding than it did 1 year ago.
- UHS has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, UHS has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.03 indicates that UHS is not in any danger for bankruptcy at the moment.
- UHS has a Altman-Z score of 3.03. This is in the better half of the industry: UHS outperforms 67.00% of its industry peers.
- The Debt to FCF ratio of UHS is 5.60, which is a neutral value as it means it would take UHS, 5.60 years of fcf income to pay off all of its debts.
- UHS has a Debt to FCF ratio (5.60) which is in line with its industry peers.
- A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
- The Debt to Equity ratio of UHS (0.55) is better than 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.6 | ||
| Altman-Z | 3.03 |
ROIC/WACC1.6
WACC7.84%
2.3 Liquidity
- UHS has a Current Ratio of 1.05. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
- UHS has a Current ratio of 1.05. This is in the lower half of the industry: UHS underperforms 67.00% of its industry peers.
- A Quick Ratio of 0.98 indicates that UHS may have some problems paying its short term obligations.
- UHS has a worse Quick ratio (0.98) than 67.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.98 |
3. UHS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 30.77% over the past year.
- The Earnings Per Share has been growing by 14.35% on average over the past years. This is quite good.
- The Revenue has grown by 9.71% in the past year. This is quite good.
- The Revenue has been growing by 8.48% on average over the past years. This is quite good.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
3.2 Future
- Based on estimates for the next years, UHS will show a small growth in Earnings Per Share. The EPS will grow by 7.50% on average per year.
- UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. UHS Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.46, the valuation of UHS can be described as very reasonable.
- 96.00% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 24.88. UHS is valued rather cheaply when compared to this.
- UHS is valuated cheaply with a Price/Forward Earnings ratio of 7.71.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 95.00% of the companies listed in the same industry.
- UHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.46 | ||
| Fwd PE | 7.71 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 89.00% of the companies in the same industry.
- UHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UHS is cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.24 | ||
| EV/EBITDA | 6.09 |
4.3 Compensation for Growth
- UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- UHS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.88
PEG (5Y)0.59
EPS Next 2Y9.29%
EPS Next 3Y9.15%
5. UHS Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.43%, UHS is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.50, UHS pays a bit more dividend than its industry peers.
- With a Dividend Yield of 0.43, UHS pays less dividend than the S&P500 average, which is at 1.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.43% |
5.2 History
- On average, the dividend of UHS grows each year by 32.23%, which is quite nice.
- UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
- UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
- UHS pays out 3.44% of its income as dividend. This is a sustainable payout ratio.
- UHS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
UHS Fundamentals: All Metrics, Ratios and Statistics
184.04
-1.05 (-0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-27 2026-04-27/amc
Inst Owners97.33%
Inst Owner Change-1.6%
Ins Owners5.83%
Ins Owner Change7.48%
Market Cap11.24B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.37
Price Target253.23 (37.6%)
Short Float %4%
Short Ratio2.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.43% |
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02 2026-03-02 (0.2)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)-0.28%
EPS NQ rev (1m)1.65%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0.43%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)1.49%
Revenue NY rev (3m)1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.46 | ||
| Fwd PE | 7.71 | ||
| P/S | 0.65 | ||
| P/FCF | 13.24 | ||
| P/OCF | 6.03 | ||
| P/B | 1.55 | ||
| P/tB | 3.42 | ||
| EV/EBITDA | 6.09 |
EPS(TTM)21.76
EY11.82%
EPS(NY)23.86
Fwd EY12.96%
FCF(TTM)13.9
FCFY7.55%
OCF(TTM)30.52
OCFY16.58%
SpS284.25
BVpS119.1
TBVpS53.78
PEG (NY)0.88
PEG (5Y)0.59
Graham Number241.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.59% | ||
| ROE | 20.46% | ||
| ROCE | 16.23% | ||
| ROIC | 12.52% | ||
| ROICexc | 12.66% | ||
| ROICexgc | 18.85% | ||
| OM | 11.48% | ||
| PM (TTM) | 8.57% | ||
| GM | N/A | ||
| FCFM | 4.89% |
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 5.6 | ||
| Debt/EBITDA | 1.53 | ||
| Cap/Depr | 164.07% | ||
| Cap/Sales | 5.85% | ||
| Interest Coverage | 12.78 | ||
| Cash Conversion | 71.36% | ||
| Profit Quality | 57.04% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 3.03 |
F-Score8
WACC7.84%
ROIC/WACC1.6
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year34.17%
EBIT Next 3Y13.52%
EBIT Next 5YN/A
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%
UNIVERSAL HEALTH SERVICES-B / UHS Fundamental Analysis FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.
How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?
The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.44%.